Qpex Biopharma is a clinical-stage biopharmaceutical company developing novel anti-infective therapies to combat drug-resistant bacterial infections and improve patient care across both inpatient and outpatient settings. The company’s pipeline centers on innovative beta-lactamase inhibitors and other antibiotics designed to address evolving antimicrobial resistance, a major global health challenge. Qpex leverages deep expertise in drug discovery and clinical development and is part of the Shionogi Group.

Acquired by Shionogi 2023